Eric Tartour spends much of his time researching Immunology, Immune system, Immunotherapy, Cytotoxic T cell and Cancer. His Immunology research integrates issues from Cancer cell and Cancer research. His research integrates issues of Immunosuppression and Monoclonal antibody in his study of Immune system.
The Immunotherapy study combines topics in areas such as Bioinformatics, Antigen-presenting cell, Interleukin 6, Melanoma and C-reactive protein. His biological study spans a wide range of topics, including Epitope, CD8 and Antigen. Eric Tartour has researched Cancer in several fields, including Lymphocyte, Immunity and Vaccination.
The scientist’s investigation covers issues in Immunology, Immune system, Internal medicine, Immunotherapy and Cancer. Eric Tartour combines subjects such as Cytotoxic T cell and Cancer research with his study of Immune system. His Internal medicine research incorporates themes from Gastroenterology and Oncology.
The study incorporates disciplines such as Clinical trial and Pathology in addition to Immunotherapy. His study in Cancer is interdisciplinary in nature, drawing from both Chemotherapy and Immunity. His work investigates the relationship between Antigen and topics such as Molecular biology that intersect with problems in Antibody and Receptor.
His scientific interests lie mostly in Internal medicine, Cancer research, Immune system, Immunotherapy and Cancer. His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. His Cancer research research is multidisciplinary, incorporating elements of CD8, Adjuvant, Ovarian cancer, Cytotoxic T cell and Lung cancer.
His studies in Immune system integrate themes in fields like Carcinoma and Computational biology. His Immunotherapy research includes themes of Epitope, Antigen and Cancer cell. His research on Immunosenescence concerns the broader Immunology.
Eric Tartour focuses on Immune system, Cancer research, CD8, Immunotherapy and Internal medicine. His research investigates the link between Immune system and topics such as Carcinoma that cross with problems in PD-L1, Head and neck cancer and Cancer. His Cancer research study incorporates themes from Immunostaining, DNA, Immunochemistry and Head and neck.
His work carried out in the field of CD8 brings together such families of science as Tumor microenvironment, Biomarker, Cytotoxic T cell, Surgical oncology and FOXP3. His Immunotherapy research integrates issues from Cancer cell and Lung cancer. His Adjuvant and Adverse effect study, which is part of a larger body of work in Internal medicine, is frequently linked to Placebo and Placebo-controlled study, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immune infiltration in human tumors: a prognostic factor that should not be ignored.
Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E.
Oncogene (2010)
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
Thibault Voron;Orianne Colussi;Elie Marcheteau;Simon Pernot.
Journal of Experimental Medicine (2015)
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
Eric Tartour;François Fossiez;Isabelle Joyeux;Annie Galinha.
Cancer Research (1999)
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki.
Immunity (2016)
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour;H. Pere;B. Maillere;M. Terme.
Cancer and Metastasis Reviews (2011)
Trial watch: Dendritic cell-based interventions for cancer therapy.
Erika Vacchelli;Ilio Vitale;Alexander Eggermont;Wolf Hervé Fridman.
OncoImmunology (2012)
Control of the immune response by pro-angiogenic factors.
Thibault Voron;Elie Marcheteau;Simon Pernot;Orianne Colussi.
Frontiers in Oncology (2014)
Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction
Philippe Menasché;Valérie Vanneaux;Albert Hagège;Alain Bel.
Journal of the American College of Cardiology (2018)
Trial watch: IDO inhibitors in cancer therapy
Erika Vacchelli;Fernando Aranda;Alexander Eggermont;Catherine Sautès-Fridman.
OncoImmunology (2014)
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.
Jonathan Pol;Erika Vacchelli;Fernando Aranda;Francesca Castoldi.
OncoImmunology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Institut Gustave Roussy
Sorbonne University
Université Paris Cité
Cornell University
Erasmus University Rotterdam
Sorbonne University
Université Paris Cité
Hôpital Européen Georges-Pompidou
Inserm : Institut national de la santé et de la recherche médicale
Publications: 24
University of Stuttgart
Syracuse University
Zhejiang University
University of Kansas
University of New England
Loyola University Chicago
Vanderbilt University
University of Duisburg-Essen
Missouri University of Science and Technology
German Aerospace Center
University of Chicago
National Institutes of Health
The University of Texas MD Anderson Cancer Center
La Trobe University
University of Toronto
Lawrence Berkeley National Laboratory